These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

249 related items for PubMed ID: 15166391

  • 1. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.
    Castellanos M, Leira R, Serena J, Blanco M, Pedraza S, Castillo J, Dávalos A.
    Stroke; 2004 Jul; 35(7):1671-6. PubMed ID: 15166391
    [Abstract] [Full Text] [Related]

  • 2. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.
    Castellanos M, Sobrino T, Millán M, García M, Arenillas J, Nombela F, Brea D, Perez de la Ossa N, Serena J, Vivancos J, Castillo J, Dávalos A.
    Stroke; 2007 Jun; 38(6):1855-9. PubMed ID: 17478737
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.
    Montaner J, Molina CA, Monasterio J, Abilleira S, Arenillas JF, Ribó M, Quintana M, Alvarez-Sabín J.
    Circulation; 2003 Feb 04; 107(4):598-603. PubMed ID: 12566373
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.
    Montaner J, Alvarez-Sabín J, Molina CA, Anglés A, Abilleira S, Arenillas J, Monasterio J.
    Stroke; 2001 Dec 01; 32(12):2762-7. PubMed ID: 11739970
    [Abstract] [Full Text] [Related]

  • 8. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC, Gupta R, Smith WS, Kamel H, Faigeles BS, Cullen SP, Rao VA, Bath PM, Wahlgren N, Ahmed N, Donnan GA, SITS International and VISTA-plus investigators.
    Int J Stroke; 2014 Aug 01; 9(6):705-10. PubMed ID: 25042855
    [Abstract] [Full Text] [Related]

  • 9. Platelet derived growth factor-CC isoform is associated with hemorrhagic transformation in ischemic stroke patients treated with tissue plasminogen activator.
    Rodríguez-González R, Blanco M, Rodríguez-Yáñez M, Moldes O, Castillo J, Sobrino T.
    Atherosclerosis; 2013 Jan 01; 226(1):165-71. PubMed ID: 23218119
    [Abstract] [Full Text] [Related]

  • 10. Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke.
    Castellanos M, Leira R, Serena J, Pumar JM, Lizasoain I, Castillo J, Dávalos A.
    Stroke; 2003 Jan 01; 34(1):40-6. PubMed ID: 12511748
    [Abstract] [Full Text] [Related]

  • 11. Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke.
    Paciaroni M, Agnelli G, Caso V, Corea F, Ageno W, Alberti A, Lanari A, Micheli S, Bertolani L, Venti M, Palmerini F, Billeci AM, Comi G, Previdi P, Silvestrelli G.
    Cerebrovasc Dis; 2009 Jan 01; 28(2):119-23. PubMed ID: 19506370
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death.
    Inzitari D, Giusti B, Nencini P, Gori AM, Nesi M, Palumbo V, Piccardi B, Armillis A, Pracucci G, Bono G, Bovi P, Consoli D, Guidotti M, Nucera A, Massaro F, Micieli G, Orlandi G, Perini F, Tassi R, Tola MR, Sessa M, Toni D, Abbate R, MAGIC Study Group.
    Stroke; 2013 Oct 01; 44(10):2901-3. PubMed ID: 23908067
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
    Thomalla G, Sobesky J, Köhrmann M, Fiebach JB, Fiehler J, Zaro Weber O, Kruetzelmann A, Kucinski T, Rosenkranz M, Röther J, Schellinger PD.
    Stroke; 2007 Feb 01; 38(2):313-8. PubMed ID: 17204683
    [Abstract] [Full Text] [Related]

  • 16. Increased Plasma Matrix Metalloproteinase-9 Levels Contribute to Intracerebral Hemorrhage during Thrombolysis after Concomitant Stroke and Influenza Infection.
    Muhammad S, Planz O, Schwaninger M.
    Cerebrovasc Dis Extra; 2016 Feb 01; 6(2):50-9. PubMed ID: 27560521
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II).
    Larrue V, von Kummer R R, Müller A, Bluhmki E.
    Stroke; 2001 Feb 01; 32(2):438-41. PubMed ID: 11157179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.